The company mainly produces prescription drugs, and the market share of Xiyanping injection, the core variety, should be the top two among similar varieties in China, especially in the urban market. At present, this variety is the only traditional Chinese medicine injection with independent intellectual property rights (compound patents) and the only national secret variety. At present, it has entered the medical insurance catalogue of 16 provinces. In addition, the company has the largest product reserve and R&D investment in the province. In recent years, the company has invested a lot of money in the modernization of traditional Chinese medicine, especially in the research of new parts of traditional Chinese medicine, focusing on the latest international mechanisms and targets to screen active substances in traditional Chinese medicine plants, and achieved initial results. At present, it has directly or indirectly owned more than 50 patents, applied for 5 national second-class new drugs and 3 third-class new drugs.
Adhering to the business philosophy of "caring for life, caring for health, putting people first and operating in good faith", and relying on the unity and wisdom of Qingfeng people, the company has been awarded the honorary titles of "Advanced Quality Management Enterprise in Jiangxi Province", "Star Enterprise in Ganzhou City" and "AA Grade Contract-abiding and Trustworthy Unit in Ganzhou City". The company will take market demand as the guide, product research and development as the core, product quality as the foundation, grasp the market outside and management inside, and wholeheartedly contribute to the cause of human health with high-quality service and good reputation!